BlackRock Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $416K | Buy |
83,733
+9,888
| +13% | +$49.1K | ﹤0.01% | 2408 |
|
|
2016
Q3 | $546K | Buy |
73,845
+1,821
| +3% | +$13.5K | ﹤0.01% | 2272 |
|
|
2016
Q2 | $393K | Buy |
72,024
+2,681
| +4% | +$14.6K | ﹤0.01% | 2340 |
|
|
2016
Q1 | $587K | Buy |
69,343
+31,166
| +82% | +$264K | ﹤0.01% | 2160 |
|
|
2015
Q4 | $370K | Sell |
38,177
-813
| -2% | -$7.88K | ﹤0.01% | 2299 |
|
|
2015
Q3 | $545K | Buy |
38,990
+10,656
| +38% | +$149K | ﹤0.01% | 2162 |
|
|
2015
Q2 | $401K | Buy |
28,334
+10,838
| +62% | +$153K | ﹤0.01% | 2330 |
|
|
2015
Q1 | $190K | Sell |
17,496
-36,619
| -68% | -$398K | ﹤0.01% | 2501 |
|
|
2014
Q4 | $450K | Buy |
54,115
+40,261
| +291% | +$335K | ﹤0.01% | 2267 |
|
|
2014
Q3 | $82K | Buy |
+13,854
| New | +$82K | ﹤0.01% | 2597 |
|